Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Washed red blood cells are a specialized blood component used in transfusion medicine where standard red blood cells undergo a washing process to remove plasma proteins, antibodies, electrolytes, and other potential allergens before transfusion. This modification is primarily used for patients who have experienced severe allergic reactions to standard blood transfusions. The washing process involves separating red blood cells from whole blood, then washing them several times with a compatible solution (typically sterile 0.9% sodium chloride/normal saline) to remove 98-99% of plasma constituents. After washing, the cells are resuspended in saline, saline with glucose, or an additive solution before transfusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on washed red blood cells.